How Much? 'Evergreening' And Drug Costs In One Swiss Town
For several years, the practice of evergreening has been a contentious topic. The term refers to patent extensions that are based on minor changes in a drug and are often employed when a patent is about to expire and modifications are used to claim a newer version of a drug has been hatched. This can allow a drugmaker to seek extended patent protection and keep the cash register ringing. The practice has prompted complaints that drugmakers exploit the strategy simply to charge higher prices for so-called follow-on drugs that offer little added benefit. South Africa, for instance, wants to change its patent laws to make the...
Source: Pharmalot - June 6, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs